BioNTech SE

Replying to @medtronic

Our membrane separation unit replaced the energy-intensive cryogenic distillation.

Replying to @grubbs

The hot-melt extrusion gave uniform drug distribution across the polymer matrix.

Replying to @bayerph

Superhydrophobic surfaces on aluminum showed self-healing after plasma treatment.

Replying to @fuhua

Glycan analysis is a key CQA. Our HILIC data aligns well with yours.

Replying to @polpharma

We use recombinant albumin fusion to extend the circulating half-life.

Replying to @poschem

Our continuous crystallization platform achieved consistent CSD control.

Replying to @conch_cement

The polymorphism of this API requires careful control during crystallization.